Novavax COVID-19 vaccine recommended for approval by FDA advisory committee

Posted on AllSides June 8th, 2022
From The Right
Serum Institute of India for Novavax via AP

A fourth COVID-19 vaccine will likely be available to Americans soon after an FDA advisory panel recommended Novavax's shot for emergency use authorization on Tuesday. 

The Vaccines and Related Biological Products Advisory Committee voted 21-0 with one abstention during a 7-hour meeting to review the company's application. 

Some health officials are hopeful that the new vaccine may appeal to the 27 million American who still are not vaccinated against COVID-19, as Novavax's shot is a more traditional protein vaccine that has been used for decades to prevent hepatitis B, shingles, and other...

Read full story

Fox Business

AllSides Media Bias Rating: Lean Right
AllSides Media Bias Rating: Lean Right
See full bias rating for Fox Business
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right